)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Sudarshan Pharma Industries
Sudarshan Pharma Industries (543828) investor relations material
Sudarshan Pharma Industries Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary29 Oct, 2026
Executive summary
Q2 FY27 consolidated revenue was ₹21,696.93 lakh and profit attributable to owners was ₹808.75 lakh; H1 revenue reached ₹39,138.77 lakh and owner profit ₹1,394.27 lakh.
Standalone Q2 revenue was ₹20,501.80 lakh and net profit ₹779.51 lakh; H1 net profit was ₹1,383.69 lakh.
Financial highlights
Consolidated Q2 revenue rose to ₹21,696.93 lakh from ₹16,886.70 lakh YoY; total income was ₹21,890.19 lakh.
Consolidated Q2 profit before tax was ₹1,080.26 lakh versus ₹422.80 lakh YoY; profit attributable to owners was ₹808.75 lakh versus ₹418.34 lakh.
Consolidated H1 revenue was ₹39,138.77 lakh and profit before tax ₹1,830.79 lakh; owner profit was ₹1,394.27 lakh.
Standalone Q2 revenue was ₹20,501.80 lakh versus ₹16,700.63 lakh YoY; net profit was ₹779.51 lakh versus ₹440.03 lakh.
Consolidated Q2 basic and diluted EPS were ₹0.31 each, versus ₹0.16 in Q2 FY26; H1 EPS was ₹0.54 versus ₹0.32.
Outlook and guidance
Palghar manufacturing closure is expected to rationalize fixed and operating costs, limit further losses, and redirect resources toward more sustainable, profitable operations.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sudarshan Pharma Industries
- USFDA-approved API facility with global clients, robust operations, and top-tier compliance.543828
Investor presentation - Year-over-year profit and revenue growth, cost rationalization, FCCB funding, and US expansion.543828Q1 26/27
- Strong revenue and profit growth, strategic expansion, and renewed FCCB fundraising drive.543828Q4 25/26
- Strong revenue and profit growth, international expansion, and major fundraising initiatives.543828Q3 25/26
- Revenue, assets, and international presence expanded, with major fundraising and acquisitions approved.543828Q2 2026
- Q1 FY26 delivered strong revenue growth and a return to profit, aided by strategic acquisitions.543828Q1 25/26
- Slight profit dip, major expansion moves, and a significant litigation win mark H1 FY25.543828Q2 24/25
- FY25 saw robust growth, acquisitions, and exceptional items impact at Sudarshan Pharma.543828Q4 24/25
Next Sudarshan Pharma Industries earnings date
Q3 26/2727 Jan, 2027
Sudarshan Pharma Industries
Next Sudarshan Pharma Industries earnings date
Q3 26/2727 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Sudarshan Pharma Industries Limited is a company engaged in the manufacturing, trading, and supply of specialty chemicals, intermediates, and pharmaceutical products. The company provides active pharmaceutical ingredients, excipients, and chemical formulations used in various industrial and pharmaceutical applications. It also offers contract manufacturing services and operates in segments such as healthcare, personal care, and chemical distribution. Sudarshan Pharma Industries Limited serves domestic and international markets through its distribution network. The company is headquartered in Mumbai, India, and its shares are listed on the BSE.